Sex-specific effects of exogenous asparagine on colorectal tumor growth, 17β-estradiol levels, and aromatase

Sex-specific effects of exogenous asparagine on colorectal tumor growth, 17β-estradiol levels, and aromatase

Sex-related differences in asparagine metabolism are associated with cancer prognosis. However, the effect of exogenous asparagine on colorectal cancer (CRC) growth in men and women remains unclear. This study aims to understand the relationship between exogenous asparagine supplementation and 17β-e...

Full description

Saved in:

Bibliographic Details
Main Authors:	Oladimeji Aladelokun, Katherine Benitez, Yuying Wang, Abhishek Jain, Domenica Berardi, Georgio Maroun, Xinyi Shen, Jatin Roper, Joanna Gibson, Kaelyn Sumigray, Sajid A. Khan, Caroline H. Johnson
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Pharmacological Research
Subjects:	Gastrointestinal cancer- colorectal Asparagine Pre-clinical models Estrogen signaling Sex differences Aromatase
Online Access:	http://www.sciencedirect.com/science/article/pii/S1043661825001616
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Selective estrogen receptor modulators and aromatase inhibitors in the treatment of functional male hypogonadism
by: Jakub Wydra, et al.
Published: (2025-08-01)

NEK8 promotes the progression of gastric cancer by reprogramming asparagine metabolism
by: Mingliang Wang, et al.
Published: (2025-01-01)

EVALUATION OF TOXICITY OF INFUSION SOLUTION OF POTASSIUM AND MAGNESIUM ASPARAGINATE 500 ML IN EXPERIMENT
by: A. G. Yushkov, et al.
Published: (2012-07-01)

Asparagine Synthetase Gene <i>OsASN2</i> Is Crucial for Rice Seed Development and Germination
by: Rui Hu, et al.
Published: (2025-06-01)

Three Asparagine insertions in the K13-propeller led to Plasmodium falciparum becoming resistant to multiple antimalarial drugs
by: Zheng Xiang, et al.
Published: (2025-08-01)

CCT196969 inhibits TNBC by targeting the HDAC5/RXRA/ASNS axis to down-regulate asparagine synthesis
by: Qiong Yuan, et al.
Published: (2025-08-01)

Detection Methods for Asparagine and Glutamine Contents in Fruits and Vegetables and Recommendations for Dietary Intake of Fruits and Vegetables in Patients with Urea Cycle Disorders
by: YE Xinyu, LI Ziying, TANG Shujun, SUN Liping, ZHAO Yunxia, XIAO Weimin, GU Yaping, KUANG Huiying, CHEN Xin, YANG Guowu, HUANG Yali
Published: (2025-02-01)

Benefits of aromatase blockers for increased testosterone in poultry: A mini-review
by: Rizki Fitrawan Yuneldi, et al.
Published: (2025-05-01)

Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma
by: Benjian Gao, et al.
Published: (2025-10-01)

17β-Hydroxysteroid dehydrogenase type I and aromatase in ovarian cortical inclusion cysts
by: Enrique Pedernera, et al.
Published: (2025-03-01)

Aromatase Gene Expression in N-Ethyl-Nitrosamine-Induced Hepatocellular Carcinoma: Hepatoprotective Effects of Grape Seed Extract and Letrozole
by: Sadia Kazi, et al.
Published: (2024-11-01)

Treatment Modalities for Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS): A Scoping Review of Prospective Treatment Studies
by: Bobo JA, et al.
Published: (2025-04-01)

Extracellular Vesicle‐Packaged Linc‐ZNF25‐1 from Pancreatic Cancer Cell Promotes Pancreatic Stellate Cell Uptake of Asparagine to Advance Chemoresistance
by: Miao Yu, et al.
Published: (2025-04-01)

THE ROLE OF AROMATASE IN THE DEVELOPMENT OF ENDOMETRIOSIS
by: L. V. Adamyan, et al.
Published: (2017-03-01)

Toxic effects of monocrotophos and glyphosate on the female reproductive organ and aromatase gene expression in climbing perch
by: Sujata Mohapatra, et al.
Published: (2025-01-01)

Association between the aromatase (CYP19A1) gene variant rs10046 and cardiovascular risk in postmenopausal women
by: Betânia Rodrigues dos Santos, et al.
Published: (2025-01-01)

Inhibition of CCT5-mediated asparagine biosynthesis and anti-PD-L1 produce synergistic antitumor effects in colorectal cancer
by: Yujie Zhang, et al.
Published: (2025-05-01)

Corneal changes in estrogen-dependent breast cancer after hormonal treatment
by: Mohamed Salah hamed Mohamed, et al.
Published: (2025-08-01)

Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysisResearch in context
by: Andri Papakonstantinou, et al.
Published: (2025-03-01)

Estrogen/androgen balance in men with hyperestrogenism normalized by using letrozole of the aromatase inhibitor drug class
by: Z. Sh. Pavlova, et al.
Published: (2022-03-01)

Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice
by: Hanieh Taheri, et al.
Published: (2025-03-01)

Two natural products from the seeds of Citrus reticulata Blanco (Rutaceae) inhibit estrogen biosynthesis by regulating the PI3K-aromatase pathway
by: Xing Yang, et al.
Published: (2025-06-01)

Comparative study of the efficacy of tamoxifen and aromatase inhibitors among breast cancer patients at Kenyatta National Hospital
by: Henry Gachoki Macharia, et al.
Published: (2025-08-01)

Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies
by: Cristina Ferreira Almeida, et al.
Published: (2024-09-01)

Plasma Proteomics and Metabolomics of Aromatase Inhibitors-Related Musculoskeletal Syndrome in Early Breast Cancer Patients
by: Feng Jing, et al.
Published: (2025-02-01)

Aromatase inhibitors can improve the semen quality of aged roosters by up regulating genes related to steroid hormone synthesis
by: Xuliang Luo, et al.
Published: (2024-12-01)

Aromatase inhibitors for short stature in male children and adolescents treated with growth hormone: a meta-analysis of randomized controlled trials
by: Kan Wang, et al.
Published: (2024-12-01)

Aromatase inhibitors therapy and major osteoporotic fracture risk in postmenopausal breast cancer patients: a nationwide real-world cohort study
by: Pin-Han Liu, et al.
Published: (2025-05-01)

Potential of Indole-3-Carbinol compounds from broccoli (Brassica oleracea var. italica) as natural aromatase blockers: In silico prediction and in vivo studies
by: Reski Amalia, et al.
Published: (2025-04-01)

Cardiovascular risks associated with adjuvant endocrine therapy in women with breast cancer: a population-based cohort study
by: Iokfai Cheang, et al.
Published: (2025-07-01)

A Review on Testosterone: Estradiol Ratio—Does It Matter, How Do You Measure It, and Can You Optimize It?
by: Arthur L. M. Swislocki, et al.
Published: (2025-07-01)

Rheumatic aspects of arthralgias associated with aromatase inhibitor therapy (analysis of a clinical case series)
by: A. D. Koltakova, et al.
Published: (2023-02-01)

Cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early oestrogen receptor-positive breast cancer: a systematic review
by: Ying X. Gue, et al.
Published: (2024-07-01)

Aromatase reduces sperm motility by down-regulating the expression of proteins related to ATP synthesis in seminal plasma extracellular vesicles
by: Xuliang Luo, et al.
Published: (2025-03-01)

Transcriptomic Profiling Reveals 17β‐Estradiol Treatment Represses Ubiquitin‐Proteasomal Mediators in Skeletal Muscle of Ovariectomized Mice
by: Georgios Kararigas, et al.
Published: (2025-02-01)

Effects of a Multimodal Program on Frailty Syndrome and Psychological Alterations in Breast Cancer Women Treated with Aromatase Inhibitors
by: Pedro Céspedes, et al.
Published: (2025-02-01)

Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
by: Peyman Hadji, et al.
Published: (2025-08-01)

Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer
by: Nicole M. G. Fleege, et al.
Published: (2025-08-01)

Lesson from a metastatic male breast cancer case: CDK4/6 plus aromatase inhibitors could not exceed tamoxifen
by: Tala Najdi, et al.
Published: (2025-05-01)

Similar fatty acid status of plasma lipids in postmenopausal women newly diagnosed with breast cancer and those receiving aromatase inhibitor therapy
by: Krstić Predrag, et al.
Published: (2021-01-01)